Relay Therapeutics (RLAY) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$17.88
+2.7% on the day
+163.7% over 12 months
52-week range $6.03 – $20.75
Share price and insider trades
RLAY closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$130M
Insiders buying0
Insiders selling5
Relay Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $130M of RLAY stock on the open market.
Get emailed when insiders cluster-buy stocks like RLAY
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
RLAY insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $1.2M | 3 |
| Q3 2026 | — | 0 | $121M | 13 |
| Q2 2026 | — | 0 | $6.2M | 12 |
| Q1 2026 | — | 0 | $903K | 8 |
| Q4 2025 | — | 0 | $1.1M | 5 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.1×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Relay Therapeutics, Inc. insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $130M. 22 of 41 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 8SEC | Sanjiv PatelCEO, President | Sell Plan | 48,199471,301 held (−9%) | $18.10 | $872K | -1.2% | — |
| Oct 8SEC | Thomas CatinazzoCFO | Sell Plan | 17,511105,340 held (−14%) | $18.58 | $325K | -3.8% | — |
| Oct 8SEC | Thomas CatinazzoCFO | Sell Plan | 206105,134 held (−0%) | $19.26 | $4K | -7.2% | — |
| Sep 9SEC | Sanjiv PatelCEO, President | Sell Plan | 48,199519,500 held (−8%) | $18.94 | $913K | -5.6% | — |
| Sep 9SEC | Thomas CatinazzoCFO | Sell Plan | 17,717122,851 held (−13%) | $18.94 | $336K | -5.6% | — |
| Sep 9SEC | Donald A BergstromPresident | Sell Plan | 8,530399,130 held (−2%) | $18.97 | $162K | -5.7% | — |
| Aug 28SEC | Investment Advisers (uk) Ltd Sb10% Owner | Sell | 6,000,00021,904,963 held (−22%) | $19.40 | $116M | -7.8% | — |
| Aug 28SEC | Peter RahmerSee Remarks | Sell Plan | 4,508223,657 held (−2%) | $20.03 | $90K | -10.7% | — |
| Aug 18SEC | Sanjiv PatelCEO, President | Sell Plan | 48,199567,699 held (−8%) | $20.33 | $980K | -12.1% | — |
| Aug 18SEC | Thomas CatinazzoCFO | Sell Plan | 17,717140,568 held (−11%) | $19.74 | $350K | -9.4% | — |
| Jul 30SEC | Donald A BergstromPresident | Sell | 2,237407,660 held (−1%) | $18.61 | $42K | -3.9% | — |
| Jul 30SEC | Thomas CatinazzoCFO | Sell | 1,459158,285 held (−1%) | $18.61 | $27K | -3.9% | — |
| Jul 30SEC | Peter RahmerSee Remarks | Sell | 748228,165 held (−0%) | $18.61 | $14K | -3.9% | — |
| Jul 8SEC | Sanjiv PatelCEO, President | Sell Plan | 48,199615,898 held (−7%) | $19.58 | $944K | -8.7% | — |
| Jul 8SEC | Thomas CatinazzoCFO | Sell Plan | 17,717159,744 held (−10%) | $18.69 | $331K | -4.3% | — |
| Jul 8SEC | Donald A BergstromPresident | Sell Plan | 8,660409,897 held (−2%) | $18.71 | $162K | -4.4% | — |
| Jul 2SEC | Peter RahmerSee Remarks | Sell Plan | 50,000225,857 held (−18%) | $19.09 | $954K | -6.3% | — |
| Jun 24SEC | Donald A BergstromPresident | Sell Plan | 93,456418,557 held (−18%) | $16.94 | $1.6M | +5.5% | — |
| Jun 24SEC | Thomas CatinazzoCFO | Sell Plan | 61,563177,461 held (−26%) | $16.97 | $1.0M | +5.4% | — |
| Jun 24SEC | Thomas CatinazzoCFO | Sell Plan | 56,323177,461 held (−24%) | $16.97 | $956K | +5.4% | — |
| Jun 24SEC | Thomas CatinazzoCFO | Sell Plan | 51,560177,461 held (−23%) | $16.97 | $875K | +5.4% | — |
| Jun 24SEC | Thomas CatinazzoCFO | Sell Plan | 17,717177,461 held (−9%) | $17.01 | $301K | +5.1% | — |
| May 14SEC | Thomas CatinazzoCFO | Sell Plan | 17,717195,178 held (−8%) | $12.86 | $228K | +39.0% | — |
| Apr 30SEC | Donald A BergstromPresident | Sell | 1,490418,557 held (−0%) | $14.79 | $22K | +20.9% | — |
| Apr 30SEC | Thomas CatinazzoCFO | Sell | 972212,895 held (−0%) | $14.79 | $14K | +20.9% | — |
| Apr 30SEC | Peter RahmerSee Remarks | Sell | 753275,857 held (−0%) | $14.79 | $11K | +20.9% | — |
| Apr 9SEC | Thomas CatinazzoCFO | Sell Plan | 17,717213,867 held (−8%) | $13.01 | $230K | +37.4% | — |
| Apr 9SEC | Thomas CatinazzoCFO | Sell Plan | 1,800213,867 held (−1%) | $15.00 | $27K | +19.2% | — |
| Mar 11SEC | Thomas CatinazzoCFO | Sell Plan | 17,717231,584 held (−7%) | $10.06 | $178K | +77.7% | — |
| Jan 29SEC | Donald A BergstromPresident | Sell | 18,895422,733 held (−4%) | $7.62 | $144K | +134.6% | — |
| Jan 29SEC | Thomas CatinazzoCFO | Sell | 13,820250,996 held (−5%) | $7.62 | $105K | +134.6% | — |
| Jan 29SEC | Peter RahmerSee Remarks | Sell | 11,684277,964 held (−4%) | $7.62 | $89K | +134.6% | — |
| Jan 29SEC | Donald A BergstromPresident | Sell | 2,686420,047 held (−1%) | $8.45 | $23K | +111.6% | — |
| Jan 29SEC | Thomas CatinazzoCFO | Sell | 1,695249,301 held (−1%) | $8.45 | $14K | +111.6% | — |
| Jan 29SEC | Peter RahmerSee Remarks | Sell | 1,354276,610 held (−0%) | $8.45 | $11K | +111.6% | — |
| Jan 7SEC | Sanjiv PatelCEO, President | Sell | 43,168661,041 held (−6%) | $7.82 | $338K | +128.6% | — |
| Nov 4SEC | Sanjiv PatelCEO, President | Sell | 62,073703,215 held (−8%) | $7.00 | $435K | +155.4% | — |
| Oct 30SEC | Donald A BergstromPresident | Sell | 30,897521,823 held (−6%) | $7.29 | $225K | +145.3% | — |
| Oct 30SEC | Peter RahmerSee Remarks | Sell | 21,394337,469 held (−6%) | $7.50 | $160K | +138.4% | — |
| Oct 30SEC | Thomas CatinazzoCFO | Sell | 21,664313,631 held (−6%) | $7.29 | $158K | +145.3% | — |
| Oct 30SEC | Peter RahmerSee Remarks | Sell | 19,135358,863 held (−5%) | $7.29 | $139K | +145.3% | — |
Insiders at Relay Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Investment Advisers (uk) Ltd Sb10% Owner | — | $116M | Aug 28, 2026 | — |
| Thomas CatinazzoCFO | — | $5.5M | Oct 8, 2026 | — |
| Sanjiv PatelCEO, President | — | $4.5M | Oct 8, 2026 | — |
| Donald A BergstromPresident | — | $2.4M | Sep 9, 2026 | — |
| Peter RahmerSee Remarks | — | $1.5M | Aug 28, 2026 | — |
RLAY stock: common questions
Are Relay Therapeutics, Inc. insiders buying RLAY stock?
In the past 12 months, 0 insiders reported open-market purchases of RLAY worth $0.
Are Relay Therapeutics, Inc. insiders selling RLAY stock?
5 insiders reported sales worth $130M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is RLAY's 52-week range?
Over the past year RLAY has traded between $6.03 and $20.75. It last closed at $17.88 on Oct 9, 2026.